Li, Zhefeng
Wang, Hongzhi
Yin, Hongran
Bennett, Chad
Zhang, Huang-ge
Guo, Peixuan
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UH3TR000875, UH3TR000875, UH3TR000875, UH3TR000875, UH3TR000875)
Article History
Received: 14 May 2018
Accepted: 6 September 2018
First Online: 2 October 2018
Competing Interests
: P.G. is the consultant of Oxford Nanopore Technologies, Inc; the cofounder of Shenzhen P&Z Bio-medical Co. Ltd and its subsidiary US P&Z Biological Technology LLC, as well as cofounder of ExonanoRNA, LLC and its subsidiary ExonanoRNA (Foshan) Biomedicine Co., LTD.